Figure 2From: Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2Kaplan–Meier survival curves for patients overall. The curves are stratified by phosphorylated Akt (P-Akt) levels. Patients whose tumors express high levels of P-Akt exhibit a significantly worse outcome in terms of disease-free survival (DFS; P < 0.01).Back to article page